Bleeding in patients undergoing percutaneous coronary interventions: A predictive model from 302,152 patients in the ACC-NCDR

被引：0
|
作者：
Mehta, Sameer [1 ]
Fruitkin, Andrew D. [1 ]
Rao, Sunil V. [2 ]
Rossi, Joe [3 ]
Ou, Fang-Shu [2 ]
Peterson, Eric D. [2 ]
Spertus, John A. [1 ]
Marso, Steven P. [1 ]
机构：
[1] Mid Amer Heart Inst, Kansas City, MO USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Northwestern Univ, Chicago, IL 60611 USA
来源：
CIRCULATION | 2007年 / 116卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3509
引用
收藏
页码：794 / 795
页数：2
相关论文
共 50 条
  • [31] Bleeding Outcomes in Patients Undergoing Combined Percutaneous Coronary Interventions plus Transcatheter Aortic Valve Replacement Time for an Adjustment to the CathPCI Bleeding Model?
    Gupta, Aakriti
    Liao, Ming
    Smyth, Emily
    Vahl, Torsten P.
    Finn, Matthew
    Fidlow, Kathryn
    Nazif, Tamim
    Leon, Martin B.
    Kodali, Susheel K.
    Kirtane, Ajay J.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (01) : 110 - 112
  • [32] Validation of Mayo clinic risk adjustment model for in-hospital mortality following percutaneous coronary interventions using the American college of cardiology-national cardiovascular data registry (ACC-NCDR)
    Singh, Mandeep
    Peterson, Eric
    Milford-Beland, Sarah
    Rumsfeld, John
    Spertus, John
    CIRCULATION, 2007, 116 (16) : 704 - 704
  • [33] Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention
    Montalescot, Gilles
    Salette, Genevieve
    Steg, Gabriel
    Cohen, Marc
    White, Harvey D.
    Gallo, Richard
    Steinhubl, Steven R.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 150 (01) : 79 - 83
  • [34] Abciximab as an adjunctive therapy for patients undergoing percutaneous coronary interventions
    Parikh, Devang
    Juergens, Craig P.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (02) : 235 - 246
  • [35] Optimal timing for percutaneous coronary interventions in patients undergoing TAVI
    Venturi, Gabriele
    Lunardi, Mattia
    Del Sole, Paolo Alberto
    Pighi, Michele
    Scarsini, Roberto
    Ribichini, Flavio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [36] Predictors of stroke in patients undergoing percutaneous coronary interventions.
    Hajj-Ali, R
    Ezzeddine, R
    Park, C
    Katz, S
    Kaplan, B
    Marchant, D
    Green, S
    Ong, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (5A): : 42G - 42G
  • [37] Optimal timing for percutaneous coronary interventions in patients undergoing TAVI
    Venturi, Gabriele
    Lunardi, Mattia
    Del Sole, Paolo Alberto
    Pighi, Michele
    Scarsini, Roberto
    Ribichini, Flavio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [38] Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
    Beitelshees, A. L.
    Horenstein, R. B.
    Vesely, M. R.
    Mehra, M. R.
    Shuldiner, A. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 455 - 459
  • [39] Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions
    Nikolsky, E
    Mehran, R
    Aymong, ED
    Mintz, GS
    Lansky, AJ
    Lasic, Z
    Negoita, M
    Fahy, M
    Pocock, SJ
    Na, YB
    Krieger, S
    Moses, JW
    Stone, GW
    Leon, MB
    Dangas, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (08): : 1023 - 1027
  • [40] Comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary interventions
    Changezi, H
    Schweiger, MJ
    Prescod, D
    Cook, JR
    CIRCULATION, 1999, 100 (18) : 187 - 187
12345